Sunday, June 2, 8:00 AM - 11:00 AM
Naoko Takebe, MD, PhD, a Senior Investigator at the Investigational Drug Branch in NCI's Division of Cancer Treatment and Diagnosis will be chairing this oral abstract session that will include 14 speakers, as well as a panel Q&A session.
|
Sunday, June 2, 4:45 PM - 6:00 PM
Join Paul Pearlman, PhD, Program Director Lead from NCI's Center for Global Health, as he chairs an education session and presents on "National Institutes of Health Efforts to Promote the Development of Affordable Innovative Cancer Technologies: Where We Are and Where We Want to Be." The session will include two other speakers, as well as a panel Q&A session.
|
Monday, June 3, 8:00 AM - 9:15 AM
David Chambers, MSc, DPhil, Deputy Director for Implementation Science in NCI's Division of Cancer Control and Population Sciences will chair this Education Session and present on "How to Implement and Disseminate Clinical Trial and Big Data Results." The session will include three other speakers as well as a panel Q&A session.
|
Monday, June 3, 11:30 AM - 12:45 PM
Stephanie L. Goff, MD, Associate Research Physician of NCI's Center for Cancer Research will present on "Tumor Infiltrating Lymphocytes Therapy." This education session follows both the Developmental Immunotherapy and Tumor Immunobiology tracks.
|
Monday, June 3, 4:45 PM - 5:45 PM
Sheila Ann Prindiville, MD, MPH, Director of NCI's Coordinating Center for Clinical Trials is presenting on " NAVIGATE Program: The National Cancer Institute/Veterans Affairs Approach to Recruiting Patients to Clinical Trials." This interactive case-base Session follows: Health Services Research, Clinical Informatics, and Quality of Care, Care Delivery and Practice Management, Clinical Trials, and Disparities/Health Equity tracks.
|
Want to learn more about what's happening across the National Cancer Institute? Visit the NCI Exhibit from Saturday, June 1- Monday June 3 to speak with staff, learn about NCI programs and initiatives at interactive kiosks, pick up free publications, and more!
We look forward to seeing you there.
|
|
No hay comentarios:
Publicar un comentario